Assertio Holdings, Inc.

Assertio Holdings, Inc. operates as a specialty pharmaceutical company in the United States. Its specialty pharmaceutical products include CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for treating migraine; Zipsor, an NSAID for relief of mild to moderate acute pain; Gralise, a once-daily formulation of gabapentin for the management of postherpetic neuralgia; NUCYNTA ER, an extended-release version of tapentadol for the management of neuropathic pain associated with diabetic peripheral neuropathy; and NUCYNTA IR, an immediate release version of tapentadol for the management of moderate to severe acute pain. Show More...

  • Website http://www.assertiotx.com
  • Sector Healthcare
  • Industry Drug Manufacturers-Specialty & Generic
  • Last Quote 0.66 USD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD 0.07 1.26 -0.53 0.75 2.05 -1.26 -1.45 -1.63 0.57 -3.07 -2.27
    Dividends USD
    Payout Ratio % *
    Shares Mil 53.0 56.0 56.0 58.0 66.0 60.0 61.0 63.0 64.0 71.0 72.0
    Book Value Per Share * USD 0.44 2.13 1.49 1.61 4.44 5.62 4.69 3.13 3.78 3.07 0.8
    Free Cash Flow Per Share * USD -0.05 1.3 -0.68 -0.03 -1.0 1.36 0.94 1.12 1.03 1.43
    Return on Assets % 4.36 56.27 -19.46 13.32 21.61 -7.3 -6.85 -9.05 3.74 -29.75 -29.32
    Financial Leverage (Average) 3.77 1.55 1.69 3.7 1.95 4.33 4.89 6.13 4.23 9.1 2.61
    Return on Equity % 20.07 109.63 -31.37 39.14 52.51 -22.29 -31.36 -48.77 18.93 -156.1 -110.51
    Return on Invested Capital % 16.64 108.98 -31.88 41.92 30.45 -3.62 -3.71 -3.31 12.98 -26.64 -48.22
    Interest Coverage 7.8 535.75 -764.95 1.85 9.91 -0.68 0.23 -0.41 1.55 -2.81 -2.27
    Current Ratio 2.41 2.75 2.6 2.15 10.74 1.41 1.35 0.74 0.85 0.56 1.47
    Quick Ratio 2.33 2.48 2.19 1.88 10.29 1.31 1.23 0.65 0.6 0.46 1.38
    Debt/Equity 0.63 2.56 2.87 3.21 2.02 4.76